Home

Reimbursement in Europe and Indication-Specific Pricing

To link to this object, paste this link in email, IM or document
To embed this object, paste this HTML in website

Reimbursement in Europe and Indication-Specific Pricing

View Description

small (250x250 max)

medium (500x500 max)

large ( > 500x500)

Full Resolution

Description

Title	Reimbursement in Europe and Indication-Specific Pricing
Subject	Life Sciences; Strategy (HC)
Description	Pricing and reimbursement systems in European markets continue to evolve. As many biologics have multiple applications, increasingly manufacturers are seeking to establish a higher price in newly approved indications, which presents many challenges.
Creator	Gaurav Misra
Date	2011/12/09
Type	Text
Format	application/pdf
Identifier	BI00050-013
Language	English
Rights	Licensed for Authorized Users at Simon Fraser University
Series	Datamonitor report
Pages	109

you wish to report:

Your comment:

Your Name:

...